World's Best Scientists 2026 revealed!
Shin-ichi Muramatsu

Shin-ichi Muramatsu

D-Index & Metrics

Neuroscience

D-Index
50
Citations
10071
World Ranking
5703
National Ranking
181

Shin-ichi Muramatsu publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Shin-ichi Muramatsu sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 237 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Shin-ichi Muramatsu D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Shin-ichi Muramatsu sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 50 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Shin-ichi Muramatsu is affiliated with Jichi Medical University in Japan and has a research portfolio spanning Neuroscience, Biochemistry, Genetics and Molecular Biology, and Medicine. Their scientific output encompasses publications in main fields such as Neuroscience with 67 papers, Biochemistry, Genetics and Molecular Biology totaling 54 publications, and Medicine with 53 contributions.

The scientist's work delves particularly into subfields including Cellular and Molecular Neuroscience (36 publications), Molecular Biology (29), Genetics (21), Cognitive Neuroscience (15), and Neurology (12). This diversity highlights a focus on both fundamental and applied aspects of brain and molecular function.

Themes addressed in their research cover several main topics: Neuroscience and Neuropharmacology Research (36 publications), Virus-based Gene Therapy Research (26), Memory and Neural Mechanisms (14), Sleep and Wakefulness Research (10), Neurotransmitter Receptor Influence on Behavior (10), Traditional Chinese Medicine Studies (10), and Neurogenetic and Muscular Disorders Research (8).

Frequent co-authors collaborating with Muramatsu include Atsumi Nitta (20 collaborations), Naotaka Izuo (15), Takashi Asano (12), Kaoru Inokuchi (7), and Hajime Miyanishi (6), indicating ongoing research partnerships within related biomedical fields.

The scientist's work has appeared in various publication venues, notably:

  • Proceedings for Annual Meeting of The Japanese Pharmacological Society (9 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (5)
  • The International Journal of Neuropsychopharmacology (5)
  • Nature Communications (4)
  • Neurochemical Research (3)

Recent papers include:

  • Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency, 2021, Molecular Therapy
  • YAP-dependent necrosis occurs in early stages of Alzheimer's disease and regulates mouse model pathology, 2020, Nature Communications
  • An ultra-stable cytoplasmic antibody engineered for in vivo applications, 2020, Nature Communications
  • Gene Therapy in a Mouse Model of Niemann-Pick Disease Type C1, 2020, Human Gene Therapy
  • Gene therapy in the putamen for curing AADC deficiency and Parkinson's disease, 2021, EMBO Molecular Medicine

Additionally, Muramatsu has contributed to literature in environmental health, with a book published by Global environmental studies: Living in the Megacity: Towards Sustainable Urban Environments (2021).

Best Publications

  • Nurr1 Is Required for Maintenance of Maturing and Adult Midbrain Dopamine Neurons

    Banafsheh Kadkhodaei;Takehito Ito;Eliza Joodmardi;Bengt Mattsson

  • A phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson's disease.

    Shin-ichi Muramatsu;Ken-ichi Fujimoto;Seiya Kato;Hiroaki Mizukami

  • Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.

    Li-Jun Wang;Yan-Yan Lu;Shin-ichi Muramatsu;Kunihiko Ikeguchi

  • Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-beta peptide in mouse brain

    Nobuhisa Iwata;Hiroaki Mizukami;Keiro Shirotani;Yoshie Takaki

  • Gene therapy for aromatic L-amino acid decarboxylase deficiency.

    Wuh-Liang Hwu;Shin-ichi Muramatsu;Sheng-Hong Tseng;Kai-Yuan Tzen

  • Triple Transduction with Adeno-Associated Virus Vectors Expressing Tyrosine Hydroxylase, Aromatic-L-Amino-Acid Decarboxylase, and GTP Cyclohydrolase I for Gene Therapy of Parkinson's Disease

    Yang Shen;Shin-Ichi Muramatsu;Kunihiko Ikeguchi;Ken-Ichi Fujimoto

  • Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria.

    Masashi Tanaka;Harm-Jan Borgeld;Jin Zhang;Shin-ichi Muramatsu

  • Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes

    Shin-Ichi Muramatsu;Ken-Ichi Fujimoto;Kunihiko Ikeguchi;Nami Shizuma

  • Isolation and Characterization of Patient-derived, Toxic, High Mass Amyloid β-Protein (Aβ) Assembly from Alzheimer Disease Brains

    Akihiko Noguchi;Satoko Matsumura;Mari Dezawa;Mari Dezawa;Mari Tada

  • Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease

    L Wang;S Muramatsu;Y Lu;K Ikeguchi

  • Synapse-specific representation of the identity of overlapping memory engrams

    Kareem Abdou;Mohammad Shehata;Kiriko Choko;Hirofumi Nishizono

  • Selective loss of nigral dopamine neurons induced by overexpression of truncated human alpha-synuclein in mice.

    Masaki Wakamatsu;Aiko Ishii;Shingo Iwata;Junko Sakagami

  • Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors

    Atsushi Handa;Shin-ichi Muramatsu;Jianming Qiu;Hiroaki Mizukami

  • Anterograde C1ql1 Signaling Is Required in Order to Determine and Maintain a Single-Winner Climbing Fiber in the Mouse Cerebellum

    Wataru Kakegawa;Nikolaos Mitakidis;Eriko Miura;Manabu Abe

  • Persistent Expression of Dopamine-Synthesizing Enzymes 15 Years After Gene Transfer in a Primate Model of Parkinson's Disease.

    Yoshihide Sehara;Ken-Ichi Fujimoto;Kunihiko Ikeguchi;Yuko Katakai

  • Na, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly

    Takayuki Ohnishi;Takayuki Ohnishi;Masako Yanazawa;Tomoya Sasahara;Tomoya Sasahara;Yasuki Kitamura

  • Efficacy and safety of AAV2 gene therapy in children with aromatic L-amino acid decarboxylase deficiency: an open-label, phase 1/2 trial.

    Yin-Hsiu Chien;Ni-Chung Lee;Sheng-Hong Tseng;Chun-Hwei Tai

  • Long-term efficacy and safety of eladocageneexuparvovec in patients with AADC deficiency

    Chun-Hwei Tai;Ni-Chung Lee;Yin-Hsiu Chien;Barry J. Byrne

  • Specific and efficient transduction of Cochlear inner hair cells with recombinant adeno-associated virus type 3 vector.

    Yuhe Liu;Takashi Okada;Kianoush Sheykholeslami;Kuniko Shimazaki

  • Gene therapy improves motor and mental function of aromatic l-amino acid decarboxylase deficiency.

    Karin Kojima;Takeshi Nakajima;Naoyuki Taga;Akihiko Miyauchi

  • Global brain delivery of neprilysin gene by intravascular administration of AAV vector in mice

    Nobuhisa Iwata;Nobuhisa Iwata;Misaki Sekiguchi;Yoshino Hattori;Akane Takahashi

  • Cerebrospinal fluid neprilysin is reduced in prodromal Alzheimer's disease.

    Masahiro Maruyama;Makoto Higuchi;Makoto Higuchi;Yoshie Takaki;Yukio Matsuba

Frequent Co-Authors

Atsumi Nitta
Atsumi Nitta University of Toyama
Keiya Ozawa
Keiya Ozawa Jichi Medical University
Hiroaki Mizukami
Hiroaki Mizukami Jichi Medical University
Hiroshi Ichinose
Hiroshi Ichinose Tokyo Institute of Technology
Toshitaka Nabeshima
Toshitaka Nabeshima Meijo University
Toshiharu Nagatsu
Toshiharu Nagatsu Fujita Health University
Takaomi C. Saido
Takaomi C. Saido RIKEN Center for Brain Science
Barry J. Byrne
Barry J. Byrne University of Florida
Kaoru Inokuchi
Kaoru Inokuchi University of Toyama
Nobuhisa Iwata
Nobuhisa Iwata Nagasaki University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're passionate about Neuroscience but want to explore a range of related fields and flexible learning options, there are several online degrees to consider. Many students start with a psychology degree to build a foundation in understanding human behavior and mental processes. This pathway is both versatile and cost-effective, suitable for those exploring interdisciplinary careers.

For those interested in supporting individuals, families, and communities, msw programs offer an accessible path toward social work and client advocacy roles. Clinical careers, such as counseling or therapy, may require advanced degrees. Aspiring psychologists can look into psyd programs online, which emphasize practical clinical skills and can often be completed remotely.

Marriage and family therapy is another rewarding pathway. Accredited mft programs can help you qualify more quickly for licensure and practice. Each of these online options supports career growth within neuroscience and mental health, all while providing the flexibility to balance studies with personal commitments.

Best Scientists Citing Shin-ichi Muramatsu

Trending Scientists

Recently Published Articles